(This September 16 story corrects third paragraph to say Woodford Investment Management, not Woodford Patient Capital Trust, has been under pressure from lawmakers and investors.)
(Reuters) - British asset manager Woodford Investment Management Ltd disclosed a less than 5% stake in Circassia Pharmaceuticals Plc (CIRCI.L) as of Sept. 13, a filing showed on Monday.
Woodford earlier held a 19.95% stake in the speciality biopharmaceutical company, according to the filing.
Woodford Investment Management has been under pressure from lawmakers and investors for not being able to meet redemption requests, after the flagship equity income fund was frozen in June.
Reporting by Samantha Machado in Bengaluru; Editing by Shailesh Kuber